• Medientyp: E-Book
  • Titel: Corporate R&D and Firm Efficiency : Evidence from Europe’s Top R&D Investors
  • Beteiligte: Kumbhakar, Subal C. [VerfasserIn]; Ortega-Argilés, Raquel [Sonstige Person, Familie und Körperschaft]; Potters, Lesley [Sonstige Person, Familie und Körperschaft]; Vivarelli, Marco [Sonstige Person, Familie und Körperschaft]; Voigt, Peter [Sonstige Person, Familie und Körperschaft]
  • Erschienen: [S.l.]: SSRN, [2010]
  • Erschienen in: IZA Discussion Paper ; No. 4657
  • Umfang: 1 Online-Ressource (31 p)
  • Sprache: Englisch
  • DOI: 10.2139/ssrn.1528592
  • Identifikator:
  • Entstehung:
  • Anmerkungen: Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments December 2009 erstellt
  • Beschreibung: The main objective of this study is to investigate the impact of corporate R&D activities on firms' performance, measured by labour productivity. To this end, the stochastic frontier technique is applied, basing the analysis on a unique unbalanced longitudinal dataset consisting of 532 top European R&D investors over the period 2000–2005. R&D stocks are considered as pivotal input in order to control for their particular contribution to firm-level efficiency. Conceptually, the study quantifies the technical inefficiency of a given company and tests empirically whether R&D activities could explain the distance from the efficient boundary of the production possibility set, i.e. the production frontier. From a policy perspective, the results of this study suggest that – if the aim is to leverage companies' productivity – emphasis should be put on supporting corporate R&D in high-tech sectors and, to some extent, in medium-tech sectors. By contrast, supporting corporate R&D in the low-tech sector turns out to have a minor effect. Instead, encouraging investment in fixed assets appears vital for the productivity of low-tech industries. However, with regard to firms' technical efficiency, R&D matters for all industries (unlike capital intensity). Hence, the allocation of support for corporate R&D seems to be as important as its overall increase and an 'erga omnes' approach across all sectors appears inappropriate
  • Zugangsstatus: Freier Zugang